塔奎妥单抗
Anti-Human CD3xGPRC5D Bispecific Antibody ( Talquetamab; JNJ-64407564; JNJ-7564)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human CD3xGPRC5D Bispecific Antibody ( Talquetamab; JNJ-64407564; JNJ-7564)
CAS2226212-40-2
Storage condition store at -20°C | Avoid repeated freeze-thaw.
Security information
Product details

Talquetamab is a first-in-class bispecific antibody targeting GPRC5D and CD3, designed to recruit and activate T cells to eliminate GPRC5D-positive multiple myeloma cells. Talquetamab (JNJ-64407564) has antitumor activity.

Related
Sorry, no related items
History
Atorolimumab
Anti-Human CD3xGPRC5D Bispecific Antibody ( Talquetamab; JNJ-64407564; JNJ-7564)
Sibeprenlimab (Synonyms: VIS649)
(R)-Sulforaphane (Synonyms: L-Sulforaphane; (R)-1-Isothiocyanato-4-(methylsulfinyl)butane; 4-Methylsulfinylbutyl isothiocyanate)
Donanemab
Icrucumab (Anti-VEGFR1 / FLT1)
Tarextumab (Anti-NOTCH3)
Vantictumab (Anti-FZD)
Anti-CD40 (iscalimab biosimilar)mAb
Dulaglutide, Acetate salt